MaxCyte Statements
MX
Data from MaxCyte`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Jun, 2024
Next reporting period:
28 Sep, 2024
Report frequency:
Quarterly
Earnings release date:
06 Aug, 2024
Expected release date:
06 Nov, 2024
MaxCyte Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
10.429
-8 %
100
1.488
14.3
8.941
-10 %
85.7
5.619
53.9
14.256
136.7
20.909
-5.9 %
200.5
-11.968
2.5 %
-114.8
2.593
24.9
—
0
-9.375
1.6 %
-89.9
—
0
-9.375
1.6 %
-89.9
-0.09
104.64
11.342
-27.6 %
100
1.403
12.4
9.939
-29.5 %
87.6
6.678
58.9
14.468
127.6
22.214
0.1 %
195.9
-12.275
-51.6 %
-108.2
2.749
24.2
—
0
-9.526
-80.5 %
-84
—
0
-9.526
-80.5 %
-84
-0.092
104.09
15.665
95.8 %
100
1.573
10
14.091
95.4 %
90
5.842
37.3
15.282
97.6
22.187
4.8 %
141.6
-8.096
42 %
-51.7
2.818
18
—
0
-5.278
53.1 %
-33.7
—
0
-5.278
53.1 %
-33.7
-0.051
103.71
8
-11.5 %
100
0.79
9.9
7.21
-6 %
90.1
6.26
78.3
13.87
173.4
21.17
2.1 %
264.6
-13.95
-6.7 %
-174.4
2.7
33.8
—
0
-11.25
-7 %
-140.6
—
0
-11.25
-7 %
-140.6
-0.11
103.45
9.04
5.4 %
100
1.38
15.3
7.67
1.2 %
84.8
5.66
62.6
14.1
156
20.74
0 %
229.4
-13.07
0.8 %
-144.6
2.56
28.3
—
0
-10.51
3.4 %
-116.3
—
0
-10.51
3.4 %
-116.3
-0.1
103.06
8.58
-30.9 %
100
1
11.7
7.58
-30.3 %
88.3
6.05
70.5
13.8
160.8
20.75
17.8 %
241.8
-13.18
-95.3 %
-153.6
2.3
26.8
—
0
-10.88
-126.2 %
-126.8
—
0
-10.88
-126.2 %
-126.8
-0.11
102.85
12.42
16.7 %
100
1.55
12.5
10.88
17.4 %
87.6
5.73
46.1
11.03
88.8
17.62
3.8 %
141.9
-6.75
12.5 %
-54.3
1.94
15.6
—
0
-4.81
25.2 %
-38.7
—
0
-4.81
25.2 %
-38.7
-0.05
102.15
10.64
10.7 %
100
1.37
12.9
9.27
9.2 %
87.1
5.33
50.1
10.95
102.9
16.98
-1.5 %
159.6
-7.71
11.8 %
-72.5
1.28
12
—
0
-6.43
22.2 %
-60.4
—
0
-6.43
22.2 %
-60.4
-0.06
101.81
9.61
-17.1 %
100
1.12
11.7
8.49
-19.3 %
88.3
4.7
48.9
12.03
125.2
17.23
17.3 %
179.3
-8.74
-110.1 %
-90.9
0.48
5
—
0
-8.26
-102.9 %
-86
—
0
-8.26
-102.9 %
-86
-0.08
103.17
11.59
14.2 %
100
1.06
9.1
10.52
17.8 %
90.8
3.77
32.5
10.47
90.3
14.69
5.8 %
126.7
-4.16
16.1 %
-35.9
0.09
0.8
—
0
-4.07
16.4 %
-35.1
—
0
-4.07
16.4 %
-35.1
-0.04
101.31
10.15
0.1 %
100
1.23
12.1
8.93
-2.9 %
88
3.35
33
9.18
90.4
13.88
19.2 %
136.7
-4.96
-103.3 %
-48.9
0.08
0.8
—
0
-4.87
-81.7 %
-48
—
0
-4.87
-81.7 %
-48
-0.05
90.62
10.14
42.6 %
100
0.94
9.3
9.2
45.6 %
90.7
2.77
27.3
8.86
87.4
11.64
8.3 %
114.8
-2.44
44.8 %
-24.06
-0.24
-2.4
—
0
-2.68
39.4 %
-26.4
—
0
-2.68
39.4 %
-26.4
-0.03
84.71
7.11
-53.5 %
100
0.78
11
6.32
-53.6 %
88.9
3.21
45.1
7.54
106
10.75
-43 %
151.2
-4.42
15.4 %
-62.2
—
0
—
0
-4.42
23.1 %
-62.2
—
0
-4.42
23.1 %
-62.2
-0.05
84.71
15.277
40.2 %
100
1.642
10.7
13.635
39.6 %
89.3
9.409
61.6
9.449
61.9
18.859
20.9 %
123.4
-5.224
10.4 %
-34.2
-0.527
-3.4
—
0
-5.75
5.2 %
-37.6
—
0
-5.75
5.2 %
-37.6
-0.074
77.31
10.892
-17.8 %
100
1.125
10.3
9.767
-17.2 %
89.7
—
0
7.265
66.7
15.6
2.3 %
143.2
-5.833
-68.5 %
-53.6
-0.233
-2.1
—
0
-6.066
-77.3 %
-55.7
—
0
-6.066
-77.3 %
-55.7
-0.098
61.619
13.247
—
100
1.456
11
11.791
—
89
7.906
59.7
7.346
55.5
15.253
—
115.1
-3.461
—
-26.1
0.041
0.3
—
0
-3.421
—
-25.8
—
0
-3.421
—
-25.8
-0.06
57.418